Business Paid
Asbis buys a 16% stake in Promed Bioscience for 0.8 mln euros
17:41
IT company Asbis acquired a 16% stake in a Cypriot biotechnology company Promed Bioscience for 800,000 euros. Promed Bioscience develops advanced collagen biomaterials for research and clinical applications.
The funds will be used to expand the company's production capacity, and…
This article is for subscribers
Warsaw Business Journal subscribers get the full archive (12,248 articles going back to 1995) and the print edition.
SubscribeOr try Poland A.M. free for 7 days, the daily briefing, or see all plans and prices.
